Occupationally acquired human immunodeficiency virus infections in laboratories producing virus concentrates in large quantities : conclusions and recommendations of an expert team convened by the director of the National Institutes of Health (NIH)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i

current


Occupationally acquired human immunodeficiency virus infections in laboratories producing virus concentrates in large quantities : conclusions and recommendations of an expert team convened by the director of the National Institutes of Health (NIH)

  • Published Date:

    April 1, 1988

  • Source:
    MMWR. Morbidity and mortality weekly report. 1988; 37 Suppl 4:19-22.
  • Language:
    English
Filetype[HTM]


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Filetype[HTM]
    Corporate Authors:
    Centers for Disease Control (U.S.) ; National Institutes of Health (U.S.) ;
    Published Date:
    April 1, 1988
    Source:
    MMWR. Morbidity and mortality weekly report. 1988; 37 Suppl 4:1-17.
    Description:
    In 1984, the Centers for Disease Control (CDC) and the National Institutes of Health (NIH), in consultation with experts from academic institutions, i...
    Status:
    current
    File Type:
    Filetype[HTM]
    File Type:
    Filetype[HTM]
  2. Filetype[HTM]
    Corporate Authors:
    National Center for Infectious Diseases (U.S.). Division of HIV/AIDS.
    Published Date:
    November 18, 1988
    Source:
    MMWR. Morbidity and mortality weekly report. 1988; 37(45):693-4, 699-704.
    Description:
    The human T-lymphotropic viruses, type I (HTLV-I) and type II (HTLV-II), are closely related but distinct retroviruses that can infect humans. They ar...
    Status:
    superseded
    File Type:
    Filetype[HTM]
    File Type:
    Filetype[HTM]
  3. Filetype[PDF - 120.88 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office of the Director.
    Published Date:
    12/16/14
    Description:
    On August 18, 2014 Assistant to the President for Homeland Security and Counterterrorism Lisa Monaco and Assistant to the President for Science and Te...
    File Type:
    Filetype[PDF - 120.88 KB]
    File Type:
    Filetype[PDF - 120.88 KB]
  4. Filetype[PDF - 526.11 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    December 16, 2014
    Description:
    In the summer of 2014, lapses in biosafety practices in Federal laboratories served as a reminder of the importance of constant vigilance over the imp...
    File Type:
    Filetype[PDF - 526.11 KB]
    File Type:
    Filetype[PDF - 526.11 KB]
  5. Filetype[PDF - 147.57 KB]
    Personal Author:
    Merlin, Toby L.
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Preparedness and Emerging Infections. ; Centers for Disease Control and Prevention (U.S.). Clinical Laboratory Improvement Advisory Committee. ;
    Conference Authors:
    Clinical Laboratory Improvement Advisory Committee. Meeting (2016 April 13-14 : Atlanta, GA)
    Published Date:
    4/5/16
    Description:
    Slides from a presentation given at the CLIAC meeting, April 14, 2016.Publication date from document properties.9_Merlin_Biosafety_CLIAC_April2016.pdf
    File Type:
    Filetype[PDF - 147.57 KB]
    File Type:
    Filetype[PDF - 147.57 KB]